Journal of Biological Chemistry
Volume 271, Issue 38, 20 September 1996, Pages 23022-23028
Journal home page for Journal of Biological Chemistry

Cell Biology and Metabolism
Identification of the Rho-binding Domain of p160ROCK, a Rho-associated Coiled-coil Containing Protein Kinase*

https://doi.org/10.1074/jbc.271.38.23022Get rights and content
Under a Creative Commons license
open access

A protein serine/threonine kinase, p160ROCK, has been identified as a putative Rho target protein that is activated when bound to the GTP-bound form of the small GTPase Rho (Ishizaki, T., Maekawa, M., Fujisawa, K., Okawa, K., Iwamatu, A., Fujita, A., Watanabe, N. Saito, Y., Kakizuka, A., Morii, N., and Narumiya, S. (1996) EMBO J. 15, 1885-1893). p160ROCK has a serine/threonine kinase domain in its NH2-terminal region, followed by an approximately 600-amino acid-long α-helix, a cysteine-rich zinc finger-like motif, and a pleckstrin homology region in the COOH terminus. To identify the Rho binding domain of this protein, we divided p160 into five fragments, expressed each as a His-tagged recombinant protein, and performed a ligand overlay assay using [35S]guanosine-5′-3-O-(thio)triphosphate (GTPγS)-bound glutathione S-transferase-RhoA. Specific GTPγS-Rho binding was observed only in the fragment M2, which covered most of the carboxyl half of the α-helix between amino acids 727 and 1021. This fragment was further subdivided into several fragments, and the ligand overlay assay as well as the yeast two hybrid system was carried out to identify the Rho-binding region. These studies localized the minimum Rho binding region to amino acids 934-1015. To identify critical amino acids for Rho binding, we analyzed the Rho binding activity of the subfragment with various point mutations. This analysis revealed that K934M, L941A, and E1008A mutations significantly weakened Rho binding and an I1009A mutation abolished Rho binding. The amino acid sequence in this region had no significant homology with Rho effector motif class 1, which is shared by putative Rho targets, PKN, rhophilin, and rhotekin, (Reid, T., Furuyashiki, T., Ishizaki, T., Watanabe, G., Watanabe, N., Fujisawa, K., Morii, N., Madaule, P., and Narumiya, S. (1996) J. Biol. Chem.271, 13556-13560) and may define a distinct class of Rho effector motif.

Cited by (0)

*

This work was supported in part by Grants-in-aid for Scientific Research from the Ministry of Education, Science and Culture of Japan 07267206, 07770080, 07273232, 07044248, 07278103, 05271103, and 07NP0901 and by grants from Human Frontier Science Program, the Naito Foundation, the Japanese Foundation on Metabolism and Diseases, and the Uehara Memorial Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.